VVT Med Inc. (VVTM : TSX-V)
Common Stock
$0.20
CAD
-0.03 (-13.04%)
Last updated: 2026-06-25
VVTM
VVT Med Inc.
WealthAwesomePerformance
1 Day
-13.04%
1 Week
-23.08%
1 Month
+5.26%
YTD
-28.57%
Key Statistics
Market Cap
$16.04M
52W High
$0.75
52W Low
$0.15
P/E Ratio
-
50 Day MA
$0.23
200 Day MA
$0.28
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/25/2026 | $0.24 | $0.24 | $0.20 | $0.20 | $0.20 | 10,874 |
| 6/24/2026 | $0.21 | $0.23 | $0.21 | $0.23 | $0.23 | 8,750 |
| 6/19/2026 | $0.25 | $0.25 | $0.24 | $0.24 | $0.24 | 1,500 |
| 6/18/2026 | $0.26 | $0.26 | $0.26 | $0.26 | $0.26 | 500 |
| 6/17/2026 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | 500 |
| 6/16/2026 | $0.27 | $0.27 | $0.27 | $0.27 | $0.27 | 1,000 |
| 6/15/2026 | $0.24 | $0.30 | $0.24 | $0.30 | $0.30 | 1,500 |
| 6/12/2026 | $0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 0 |
| 6/11/2026 | $0.25 | $0.25 | $0.20 | $0.22 | $0.22 | 7,613 |
| 6/10/2026 | $0.31 | $0.31 | $0.27 | $0.27 | $0.27 | 3,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VVTM's historical volatility
30-Day Vol
218.6%
Annualized
90-Day Vol
186.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.17
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.19 | C$0.09 – C$0.40 |
| 60 trading days | C$0.18 | C$0.06 – C$0.52 |
| 90 trading days | C$0.17 | C$0.05 – C$0.62 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel.
Financials
- Revenue (TTM)
- $112,000
- EBITDA
- $-1.82M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.07
- Book Value
- -0.01
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About VVTM
Articles Featuring VVTM.V
Latest articles and analysis covering VVTM.V
